Animal Health net sales were USD 293.0 million, against USD 283.5 million, and the segment's adjusted EBITDA was USD 73.9 million, against USD 74.9 million. Sales of medicated feed additives and other products rose to USD 206.5 million from USD 195.2 million, which management …
TheCash Flow Statementshows how theBalance Sheetchanged. Over nine months, Paycom borrowed USD 900.0 million under itsCreditfacility, repaid USD 150.0 million and repurchased common stock for USD 1,390.9 million, against USD 218.9 million in the same period of 2025. Long-termDebtwas USD 750.0 million at September …
The company attributed the warrant decrease primarily to lower common stock and public warrant values and a shorter remaining term to expiration. A year earlier, the same line showed a USD 23.75 million decrease. The warrants were extended in 2026 and now expire on …
Management said the OPUS-1 trial enrolled 3,572 adults aged 50 and older, plus 475 adults aged 18 to 49, and compared VAX-31 head to head with PCV20 and PCV21. The company reported that VAX-31 met all prespecified primary endpoints. All 28 serotypes shared with …
The company stated that the majority of its future revenues for the foreseeable future come from Papzimeos sales as commercial activities expand. It said its transition to sustained profitability depends on continued commercialization of Papzimeos and potential commercialization of other candidates. It reported profitability …
The company had 607 fertility and family building clients at September 30, 2026, against 553 a year earlier. Average members were 7,176,000 in the quarter, against 6,757,000. Management said the majority of the new clients and lives are stated to go live in the …
Operating income was USD 38 million, against USD 59 million, aMarginof 6.4% against 9.7%. Adjusted EBITDA was USD 135 million, up 4.0% from USD 130 million, and Adjusted FFO attributable to stockholders was USD 79 million, against USD 70 million. Diluted Adjusted FFO per …
Chairman and Chief Executive Matthew V. Crawford said the global industrial economy, led by North America, continues to support the company, and that demand has been ahead of plan throughout the year. He pointed to semiconductor, electrical infrastructure and aerospace and defense, and said …
The full year range is stated for adjusted net income, a non-GAAP measure, and the company did not provide a reconciliation to GAAP net income, citing items it cannot predict. The Board declared a quarterlyCash Dividendof USD 0.45 per share on October 29, 2026, …
Segment revenue for home health and hospice was USD 239.81 million against USD 173.55 million, with segment adjusted EBITDAR from operations of USD 41.37 million against USD 29.07 million. Total home health admissions were 28,479 against 20,426, including 11,347Medicareadmissions against 8,221. Average Medicare revenue …